| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 6425-39-4 | 2,2-二嗎啉基二乙基醚 | 2,2-Dimorpholinodiethylether; 4,4'-(Oxydi-2,1-ethanediyl)bismorpholine |  | C12H24N2O3 | 詳情 | 供應(yīng)商 |
| 857637-25-3 | Carbamic acid,N-[2-(3-hydroxy-1-piperidinyl)ethyl]-, 1,1-dimethylethyl ester; Carbamicacid, [2-(3-hydroxy-1-piperidinyl)ethyl]-, 1,1-dimethylethyl ester (9CI) |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 17665-02-0 | L-亮氨酰-D-亮氨酸二水 | D-Leucine, L-leucyl-; D-Leucine,N-L-leucyl-; Leucine, N-L-leucyl-, D- (8CI); L-Leucyl-D-leucine; Leucyl-D-leucine |  | C12H24N2O3 | 詳情 | 供應(yīng)商 |
| 2883-36-5 | Leucine, leucyl-; DL-Leucine,N-DL-leucyl-; Leucine, N-DL-leucyl-, DL- (7CI,8CI); DL-Leu-DL-leu; DL-Leucyl-DL-leucine |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 42537-99-5 | L-Isoleucine,L-isoleucyl-; Isoleucine,N-isoleucyl- (7CI); L-Isoleucine, N-L-isoleucyl-; Isoleucylisoleucine |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 36077-41-5 | L-Isoleucine, L-leucyl-; L-Isoleucine,N-L-leucyl-; L-Leucyl-L-isoleucine; Leucylisoleucine |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 681809-31-4 | L-Valine,N-[[(1,1-dimethylethyl)methylamino]carbonyl]-3-methyl- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 5136-16-3 | Hexanoic acid,6-[(6-aminohexyl)amino]-6-oxo-; Valericacid, 5-[(6-aminohexyl)carbamoyl]- (6CI,7CI,8CI) |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 132710-90-8 | 1-Piperazinecarboxylicacid, 4-(3-hydroxypropyl)-, 1,1-dimethylethyl ester; 1-(tert-Butoxycarbonyl)-4-(3-hydroxypropyl)piperazine; 4-(3-Hydroxypropyl)piperazine-1-carboxylic acid tert-butyl ester; tert-Butyl4-(3-hydroxypropyl)piperazine-1-carboxylate |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 745738-05-0 | 1-Piperazinecarboxylicacid, 4-(2-hydroxypropyl)-, 1,1-dimethylethyl ester; 4-(2-HYDROXY-PROPYL)-PIPERAZINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 887581-35-3 | 1-Azetidinecarboxylicacid, 3-[(3-methoxypropyl)amino]-, 1,1-dimethylethyl ester; 1-BOC-3-(3-METHOXY-PROPYLAMINO)-AZETIDINE |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 156206-03-0 | 1,7,8-Indolizinetriol,6-(diethylamino)octahydro-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-(diethylamino)octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 156205-80-0 | 1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(1-methylpropyl)aminomethyl-; 1H-Pyrrolizine-1,2,7-triol, hexahydro-3-(1-methylpropyl)aminomethyl- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 156205-79-7 | 1,7,8-Indolizinetriol,octahydro-6-[(1-methylpropyl)amino]-; 1,7,8-Indolizinetriol, octahydro-6-(1-methylpropyl)amino- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 156205-77-5 | 1,7,8-Indolizinetriol,octahydro-6-[(2-methylpropyl)amino]-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, octahydro-6-(2-methylpropyl)amino-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 156205-76-4 | 1H-Pyrrolizine-1,2,7-triol,3-[(butylamino)methyl]hexahydro-, [1R-(1a,2b,3a,7b,7aa)]- (9CI); 1H-Pyrrolizine-1,2,7-triol, 3-(butylamino)methylhexahydro-, 1R-(1.alpha.,2.beta.,3.alpha.,7.beta.,7a.alpha.)- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 156205-75-3 | 1,7,8-Indolizinetriol,6-(butylamino)octahydro-, [1S-(1a,6b,7a,8b,8ab)]- (9CI); 1,7,8-Indolizinetriol, 6-(butylamino)octahydro-, 1S-(1.alpha.,6.beta.,7.alpha.,8.beta.,8a.beta.)- |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 26462-22-6 | H-ILE-LEU-OH | H-ILE-LEU-OH; L-ISOLEUCYL-L-LEUCINE; L-ILE-L-LEU; H-ILE-LEU-OH |  | C12H24N2O3 | 詳情 | 供應(yīng)商 |
| 37095-49-1 | KRYPTOFIX 111; KRYPTOFIX(R) 111; KRYPTOFIX 111; 4,10,15-TRIOXA-1,7-DIAZABICYCLO-[5,5,5]HEPTADECANE; KRYPTOFIX 111 99+% |  | C12H24N2O3 | 詳情 | 供應(yīng)商 | |
| 38689-31-5 | H-D-LEU-LEU-OH | H-D-LEU-LEU-OH; D-LEUCYL-L-LEUCINE; D-LEU-L-LEU; H-D-LEU-LEU-OH; D-LEU-LEU; (S)-2-[[(R)-2-Amino-4-methylvaleryl]amino]-4-methylvaleric acid; D-Leu-L-Leu-OH |  | C12H24N2O3 | 詳情 | 供應(yīng)商 |